Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.4303
-0.0123 (-2.78%)
At close: Jul 30, 2025, 4:00 PM
0.4302
-0.0001 (-0.02%)
After-hours: Jul 30, 2025, 4:11 PM EDT
APLT's stock price has decreased by -91.28% in the past year and price targets may not have had time to catch up.
Applied Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$6.10
Upside
+1,317.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +248.59% | May 14, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +248.59% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +364.79% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +1,759.17% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +1,061.98% | Nov 29, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +829.58% | Nov 29, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +2,921.15% | Nov 27, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +2,456.36% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +3,153.54% | Sep 19, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +1,759.17% | Aug 27, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 31, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +2,688.75% | Jul 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +2,688.75% | Apr 11, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $12 | Buy | Initiates | $12 | +2,688.75% | Mar 26, 2024 |
| UBS | UBS | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +2,921.15% | Mar 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.